Category: Podcasts

Cannabis And Advertising

Should cannabis companies be allowed to advertise their products? We talk about the current advertising restrictions for medical cannabis and whether or not they should apply to the recreational industry.

Featuring:

Ian Chamandy, Founding Partner of Blueprint Business Architecture; John Fowler, CEO of Supreme Pharmaceuticals; Rebecca Jesseman, Senior Policy Advisor at the Canadian Centre on Substance Abuse; Deepak Anand, Executive Director of the Canadian National Medical Marijuana Association; Will Stewart, Managing Principal at Navigator Ltd.

The Genetics Bottleneck

What does legalizing cannabis at the federal level really mean? We use the genetics bottleneck to look at federal regulation for recreational consumption in Canada.

Featuring:

David Brown, Communications Director and Editor-in-Chief at Lift; Will Stewart, Managing Principal at Navigator Ltd.; Deepak Anand, Executive Director of the Canadian National Medical Marijuana Association.

Creating policy for recreation consumption of cannabis is not an easy task. There’s a natural tension between public health and industry interests and this week we’re discussing the public health perspective on legalization.

Featuring:

Rebecca Jesseman, Senior Policy Advisor at the Canadian Centre on Substance Abuse; Mark Pugash, Director of Corporate Communications, Toronto Police Service; Marcus Charles, Co-founder of JUJU Joints.

Colorado, Washington, and Canada

This week, we’re looking at other states that have gone through legalization. We’re comparing regulations in Colorado and Washington and discussing how they could apply to Canada.

Featuring:

John Prentice, CEO of Ample Organics; Rosy Mondin, Executive Director of the Cannabis Trade Alliance of Canada; Marcus Charles, Co-founder of JUJU Joints; Rebecca Jesseman, Senior Policy Advisor at the Canadian Centre on Substance Abuse.